Clinical Oncology and Cancers

Clinical Oncology and Cancers - formerly known as Mathews Journal of Cancer Science, serves as the most reliable and authoritative platform for conveying important clinical oncology and cancer research to its readers. Its multidisciplinary approach enables readers to keep abreast of developments in their own and allied fields. Our aim is to publish exceptional studies that make significant contributions to various sectors of clinical oncology and cancer research. Given the rising time pressure on healthcare practitioners and clinicians, we strive hard to make it as easy as possible for our Fellow readers to access the newest research in the field of clinical oncology and cancer. It publishes a blend of high-quality original research, informative editorials, case studies, insightful Editorials, Commentaries, and up-to-date reviews on all aspects of cancer patient care, including types of cancer, stages of cancer, disease pathology, malignant diseases, impact of COVID on cancer and its treatment, novel diagnostic and therapeutic approaches, epidemiology, palliative care, mechanisms underlying this complex disease, novel and timely investigations in cancer research, etiology of cancer, essential pre-clinical and translational oncology research.

The journal is well-positioned and it accepts manuscripts that deal with the wide range of cancer behavior, outcome, and management techniques adopted in clinical oncology and cancer. Clinical Oncology and Cancers Journal publishes high-quality, influential basic and clinical research publications by both established academic authors and emerging researchers. Its primary goal is to highlight and promote outstanding research in the field of oncology in order to improve the field's progress.

Clinical Oncology and Cancers Journal has assembled an expert Editorial Board composed of prominent scientists who ensure that each paper is fairly but rigorously peer-reviewed in order to provide highly impactful and original content. We take great pride in providing authors with a smooth and pleasant publishing experience.

Why publish with us?

• We encourage papers on clinical trials, particularly prospective randomized studies, in our journal, which cover all aspects of clinical oncology and present the outcomes of fresh and timely investigations.
• We offer a clear and supportive publication process, as well as significant publicity for your work through marketing, societies, and libraries.
• The journal has an open access policy, which means that the journal's published articles are accessible to anyone all over the world.
• We send article alerts and regular email updates to subscribers through our social media channels once the article has been published online.
• Every manuscript submitted is subjected to a comprehensive and rigorous double-blind peer review.
• Our broad scope ensures that the work we publish reaches the widest possible audience. We are interested in the best research from across the whole spectrum of clinical oncology.
• Our editors collaborate with academic partners to identify the most significant topics in cancer - in science, medicine, and global health.